Atlas Trials

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Clinical trial NCT05642793 · UNKNOWN

Trial details

NCT number
NCT05642793
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy
Start date
2022-04-01
Primary completion
2023-09-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.